More commonly found on the face, SCCs like BCCs are mostly treated with Surgery. This entails excision and skin closure. These common tumours leave defects which often cannot close by simple skin direct closure but necessitate reconstructive techniques such as local flaps or skin grafts.
Using techniques learned in the UK and Australia, Mr Potter will reconstruct using principals used in aesthetic surgery to place as many incisions on natural skin folds to hide surgical scars as well as maintain as much function as possible.
Unlike BCCs, Squamous Cell Carcinomas have a small potential to spread (2%). For this reason patients with SCCs Mr Potter treats will have the benefit of having their case put before a multidisciplinary skin cancer meeting. This provides reassurance to the patient that we are reviewing their case by a panel of Doctors skilled in the art of skin cancer. All treatment modalities including Surgery will discussed.
Matthew has extensive expertise treating complex SCC patients which includes a disease process which has spread to the lymph glands. Mr Potter will monitor for any spread of the disease through long term follow up and has the experience of being able to remove any spread of disease to the regional lymph glands (Groin, Armpit and Neck). Mr Potter has published the second largest series world wide on Squamous Cell Carcinomas.
Please click here to read testimonials and feedback from Matthew Potter’s patients.
The Data:
Mr Potter is the senior author of the UKs largest series of Squamous Cell Carcinomas. This series is the second largest series world wide.
Mr Potter has also separately published on excision margins for SCCs and the need for specialist skills of excisional surgeons when dealing with complex head and neck tumours where the deep margin is critical.
National average for complete peripheral excision rate of SCCs in minor surgery
95%
Mr Potter’s complete peripheral excision rate of SCCs in minor surgery
99%
Number of local flaps lost in reconstructing defects following SCC excision (last 3 years)
0%
Number of full thickness skin grafts lost in reconstructing defects following SCC excision (last 3 years)
0%
Percentage return to theatre following SCC excision
<1%